What Researchers Did
A Canadian author reviewed five non-drug measures that might limit brain damage from ischemia, meaning reduced blood flow to the brain, and argued that they should be tested in clinical trials.
What They Found
This narrative review of five physiologic measures for brain ischemia found that hypothermia was protective in both focal and global ischemia, and that the other four measures (insulin, controlled arterial hyperoxemia, blood pressure control and magnesium) also had supporting evidence, some of it experimental. The author notes that clinical trials of drugs for ischemic stroke have had a series of disappointing negative results. Hypothermia protected even when started after the ischemia. Its benefit depends on the delay, depth and duration of cooling. Controlled arterial hyperoxemia seemed effective experimentally in reducing infarct size. Raising blood pressure improved collateral blood flow and reduced stroke size, but hemorrhage must be ruled out first. In aneurysm patients with vasospasm, minor blood pressure increases reversed temporary hemiparesis. Magnesium and insulin together were shown effective in experimental brain ischemia.
Canadian Relevance
The study is marked as having a Canadian connection.
Study Limitations
The abstract describes mostly experimental evidence and a few clinical observations rather than controlled human trials, and the author states that the five measures still need to be tested in clinical trials.